Suggested Topics within your search.
Showing 1,881 - 1,900 results of 2,226 for search 'show trial', query time: 0.12s Refine Results
  1. 1881

    Exploring nurse-led cystoscopy: A systematic review of safety, efficacy, and applicability in urogynecology by Aditi Siddharth, Nadia Muspratt Tucker, Rufus Cartwright

    Published 2024-01-01
    “…Further research and randomized controlled trials are needed to strengthen the evidence in this field.…”
    Get full text
    Article
  2. 1882

    The Impact of Polyunsaturated Fatty Acid Supplementation on Inflammatory Markers in Preterm Infants – A Literature Review by Larysa Bielecka

    Published 2025-01-01
    “…Research consistently shows that PUFA supplementation lowers IL-6 levels, a cytokine considered a risk factor for sepsis in preterm infants. …”
    Get full text
    Article
  3. 1883

    Severe Necrotizing Adenovirus Tubulointerstitial Nephritis in a Kidney Transplant Recipient by Ravi Parasuraman, Ping L. Zhang, Dilip Samarapungavan, Leslie Rocher, Alan Koffron

    Published 2013-01-01
    “…Cidofovir is considered the agent of choice for AdV infection in immunocompromised despite lack of randomized trials, and the addition of intravenous immunoglobulin may aid in resolution of infection while help prevention of rejection.…”
    Get full text
    Article
  4. 1884

    Tirosin Kinase Inhibitors in Chronic Graft versus Host Disease: From Bench to Bedside by Jacopo Olivieri, Sabrina Coluzzi, Imma Attolico, Attilio Olivieri

    Published 2011-01-01
    “…Translation to the clinical setting revealed that treatment with Imatinib can achieve encouraging responses in patients with autoimmune diseases and steroid-refractory cGVHD, showing a favourable toxicity profile. While the exact mechanisms leading to such efficacy are still under investigation, use of TKIs in the context of clinical trials should be promoted, aiming to evaluate the biological changes induced in vivo by TKIs and to assess the long term outcome of these patients. …”
    Get full text
    Article
  5. 1885

    An sveir model for assessing potential impact of an imperfect anti-SARS vaccine by Abba B. Gumel, C. Connell McCluskey, James Watmough

    Published 2006-04-01
    “…Owing to the recent ongoing clinical trials ofsome candidate anti-SARS vaccines, this study aims to assess, via mathematical modelling, the potential impact of a SARS vaccine,assumed to be imperfect, in curtailing future outbreaks. …”
    Get full text
    Article
  6. 1886

    Minimally invasive lateral, posterior, and posterolateral sacroiliac joint fusion for low back pain: a systematic review and meta-analysis by Kai Xu, Ya-Ling Li, Song-Hua Xiao, Yong-Wei Pan

    Published 2025-02-01
    “…Methods The PubMed, Web of Science, Embase, Cochrane Library, and ClinicalTrials.gov databases were comprehensively searched for studies up to 31 August 2024. …”
    Get full text
    Article
  7. 1887

    Survival Analysis of Diabetic Colorectal Cancer Patients on Metformin by Alex Brandon Wong, Ravi Patnaik, Li Ling Chaw, Shir Kiong Lu, Long Chiau Ming, Wen Han Chooi, Ya Chee Lim

    Published 2023-12-01
    “…However, the association between cancer progression and metformin use requires further investigation, and high-powered clinical trials are needed to support these findings. …”
    Get full text
    Article
  8. 1888

    Application of ectoine in diseases of the skin and mucous membranes by Piotr Kuna, Dominika Ochab-Krupnik, Anna Mościcka, Piotr Łacwik

    Published 2024-06-01
    “…Additionally, ongoing research shows its potential in pulmonary, gastroenterological, and neurological treatment. …”
    Get full text
    Article
  9. 1889

    Environmental Enrichment Therapy for Autism: Outcomes with Increased Access by Eyal Aronoff, Robert Hillyer, Michael Leon

    Published 2016-01-01
    “…We have previously shown in two randomized clinical trials that environmental enrichment is capable of ameliorating symptoms of autism spectrum disorder (ASD), and in the present study, we determined whether this therapy could be effective under real-world circumstances. 1,002 children were given daily Sensory Enrichment Therapy, by their parents, using personalized therapy instructions given over the Internet. …”
    Get full text
    Article
  10. 1890
  11. 1891

    Measurement of Voice Onset Time in Maxillectomy Patients by Mariko Hattori, Yuka I. Sumita, Hisashi Taniguchi

    Published 2014-01-01
    “…We examined voice onset time for /ka/ and /ta/ in 13 maxillectomy patients by calculating the number of valid measurements of voice onset time out of three trials for each syllable. Wilcoxon’s signed rank test showed that voice onset time measurements were more successful for /ka/ and /ta/ when a prosthesis was used (Z=−2.232, P=0.026 and Z=−2.401, P=0.016, resp.) than when a prosthesis was not used. …”
    Get full text
    Article
  12. 1892

    Dietary Fatty Acids and Predementia Syndromes by Vincenzo Solfrizzi, Vincenza Frisardi, Cristiano Capurso, Alessia D' Introno, Anna M. Colacicco, Gianluigi Vendemiale, Antonio Capurso, Francesco Panza

    Published 2009-01-01
    “…However, recent findings from clinical trials with n-3 PUFA supplementation showed efficacy on depressive symptoms in non–Vapolipoprotein E (APOE) ε4 carriers, and on cognitive symptoms only in very mild Alzheimer's disease (AD) subgroups, MCI patients, and cognitively unimpaired non-APOE ε4 carriers. …”
    Get full text
    Article
  13. 1893

    Comparative analysis of Oreochromis niloticus responses to Chlorella vulgaris and Lactobacillus-fermented Azolla economic feed supplements in biofloc and green systems: An in silic... by Ahmed M. Aboseif, Nasser S. Flefil, Mostafa K.S. Taha, Asmaa Negm El-Dein, Mingchun Ren, Hualiang Liang, Abd-Ellatif M. Hussian

    Published 2025-03-01
    “…The fermentation process, involving Lactobacillus plantarum KU985433 and L. rhamnosus KU985437, enhances Azolla’s protein, phenolic, and antioxidant content while reducing carbohydrates and lipids. Comparative trials in biofloc and green water systems showed that fish fed with fermented Azolla exhibited improved growth, feed utilization, and immune response, demonstrating the potential of fermented plant-based feed as a sustainable alternative to conventional soybean meal. …”
    Get full text
    Article
  14. 1894

    Autologous Bone Marrow Mononuclear Cells in Ischemic Cerebrovascular Accident Paves Way for Neurorestoration: A Case Report by Alok Sharma, Hemangi Sane, Anjana Nagrajan, Nandini Gokulchandran, Prerna Badhe, Amruta Paranjape, Hema Biju

    Published 2014-01-01
    “…The striking fact was that the hand functions, which are the most challenging deficits, showed significant recovery. Functional Independence Measure scores and quality of life improved. …”
    Get full text
    Article
  15. 1895

    The Role of Platelet Concentrates and Growth Factors in Facial Rejuvenation: A Systematic Review with Case Series by Giuseppina Malcangi, Angelo Michele Inchingolo, Alessio Danilo Inchingolo, Laura Ferrante, Giulia Latini, Irma Trilli, Paola Nardelli, Marialuisa Longo, Andrea Palermo, Francesco Inchingolo, Gianna Dipalma

    Published 2025-01-01
    “…The case series that goes with it shows real-world examples of how to improve skin elasticity, texture, and general facial appearance with little negative side effects. …”
    Get full text
    Article
  16. 1896

    The Role of Angiotensin Antagonism in Coronary Plaque Regression: Insights from the Glagovian Model by Abdul H. Alkatiri, Doni Firman, Amir A. Alkatiri, Paskalis I. Suryajaya, Albert Sudharsono

    Published 2021-01-01
    “…Analysis from various trials utilizing ARB showed a significant plaque regression using olmesartan and telmisartan as evaluated by IVUS studies. …”
    Get full text
    Article
  17. 1897

    Effects of virtual reality technology on early mobility in critically ill adult patients: a systematic review and meta-analysis by Yansha He, Yansha He, Qin Yang, Xiaoxia Dai, Tian Chen, Huan Wu, Kunjie Li, Shiqiong Zhu, Yanlin Liu, Hua Lei

    Published 2025-02-01
    “…To evaluate the quality of the included studies, the risk of bias was assessed using the RevMan 5.4 tool.ResultsA total of 11 randomized controlled trials (RCTs) published over 10 years were included, involving 880 critically ill adult patients: 435 in the experimental group and 445 in the control group. …”
    Get full text
    Article
  18. 1898

    The generation and evaluation of TKO/hCD55/hTM/hEPCR gene-modified pigs for clinical organ xenotransplantation by Guoli Huai, Yong Wang, Jiaxiang Du, Zhenhui Cheng, Yuxuan Xie, Jia Zhou, Hongmei Tang, Yanyan Jiang, Xiangyang Xing, Shaoping Deng, Dengke Pan, Dengke Pan, Dengke Pan

    Published 2025-01-01
    “…However, the optimal combination of genetic modifications and their expression levels for initial clinical trials remains unclear. This study investigates the generation of TKO/hCD55/hTM/hEPCR (6GE) pigs and evaluates their compatibility with human immune and coagulation systems.MethodsThe 6GE pigs were generated through iterative genome editing and F1 generation breeding. …”
    Get full text
    Article
  19. 1899

    The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Ana... by Xiaorui Lyu, Taibiao Lyu, Xue Wang, Huijuan Zhu, Hui Pan, Linjie Wang, Hongbo Yang, Fengying Gong

    Published 2021-01-01
    “…All randomized controlled trials (RCTs) which reported the efficacy of GLP-1RAs and MET in overweight/obese PCOS patients in Medline (from Pubmed), Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Scopus databases were independently searched by two reviewers. …”
    Get full text
    Article
  20. 1900

    CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer by Carlos M Roggero, Anwesha B Ghosh, Anvita Devineni, Shihong Ma, Eliot Blatt, Ganesh V. Raj, Yi Yin

    Published 2025-02-01
    “…Despite widespread deregulation of CDK4/6 activity in non-small cell lung cancer (NSCLC), clinical trials with CDK4/6 inhibitor (CDK4/6i) as a monotherapy have shown poor antitumor activity. …”
    Get full text
    Article